GENETIX BIOTHERAPEUTICS
LIVE

Serial Number

99399475

Owner

Genetix Biotherapeutics Inc.

Attorney

Christopher K. Albert

First Use Date

Apr 29, 2026

Filing Date

Sep 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

GENETIX BIOTHERAPEUTICS Trademark

Serial Number: 99399475 • Registration: 8506462

GENETIX BIOTHERAPEUTICS is a trademark filed by Genetix Biotherapeutics Inc. on September 18, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Genetix Biotherapeutics Inc. (63 trademarks)

455 Grand Union Boulevard
Somerville, MA 02145

Entity Type: 03

GENETIX BIOTHERAPEUTICS INC.

455 GRAND UNION BOULEVARD
SOMERVILLE, MA 02145

Entity Type: 03

Trademark Details

Filing Date

September 18, 2025

Registration Date

October 13, 2026

First Use Anywhere

April 29, 2026

First Use in Commerce

April 29, 2026

Goods & Services

Pharmaceutical research and development; Research and development in the field of genetic diseases and gene therapies

Providing medical information in the field of genetic diseases and gene therapies; Providing a website featuring medical information in the field of genetic diseases and gene therapies; Medical information services provided via the internet; Providing educational information relating to genetic diseases and treatment for genetic diseases; Providing educational information via the internet relating to genetic diseases and treatment for genetic diseases; Providing a website that features educational information relating to genetic diseases and treatment for genetic diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 13, 2026 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Oct 13, 2026 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Sep 17, 2026 CNTA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 17, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Sep 17, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Sep 17, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 17, 2026 CNEA
USE AMENDMENT ACCEPTED
Sep 17, 2026 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Aug 18, 2026 AUPC
USE AMENDMENT FILED
Aug 18, 2026 IUAF
TEAS AMENDMENT OF USE RECEIVED
Aug 18, 2026 EAAU
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 18, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 4, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 4, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 18, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 18, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 18, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2026 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 30, 2025 ASGN
APPLICATION FILING RECEIPT MAILED
Sep 18, 2025 MAFR
NEW APPLICATION ENTERED
Sep 18, 2025 NWAP